The Vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis [5]

Journal of Dermatological Science

Volumn 34, Issue 1, 2004, Pages 62-66

  Ikeda, Takaharu ^a   Uede, Koji ^a   Furukawa, Fukumi ^a   Hashizume, Hideo ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCILLAMINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETRETINATE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; RETINOL DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; ALOPECIA; CHILITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERLIPIDEMIA; LETTER; OINTMENT; PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCLERODERMA; SCORING SYSTEM; SIDE EFFECT; SKINFOLD; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

EID: 1642538299     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2003.11.007     Document Type: Letter

References (7)

1. Brennan P., Silman A., Black C., Bernstein R., Coppock J., Maddison P., Sheeran T., Stevens C., Woliheim F. Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J. Rheumatol. 31:1993;457-460.
2. Binks M., Passweg J.R., Furst D., McSweeney P., Sullivan K., Besenthal C.et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann. Rheum. Dis. 60:2001;577-584.
3. Bahmer F.A., Zaun H. Isotretinain therapy for progressive systemic sclerosis. Arch. Dermatol. 121:1985;308.
4. Mizutani H., Yoshida T., Nouchi N., Hamanaka H., Shimizu M. Topical tocoretinate improved hypertropic scar, skin sclerosis in systemic sclerosis and morphea. J. Dermatol. 26:1999;11-17.
5. Marcellus D.C., Altomonte V.L., Farmer E.R., Horn T.D., Freemer C.S., Grant J.et al. Etretinate therapy for refractory scierodermatous chronic graft-versus-host disease. Blood. 93:1999;66-70.
6. Delany A.M., Brinckerhoff C.E. The synthetic retinoid (4-hydroxyphenyl)retinamide decreases collagen expression in vitro and in the tight-skin mouse. Arthritis Rheum. 36:1993;983-993.
7. Ohta A., Uitto J. Procollagen gene expression by scleroderma fibroblasts in culture. Inhibition of collagen production and reduction of pro alpha 1 (I) and pro alpha 1(III) collagen messenger RNA steady-state levels by retinoids. Arthritis Rheum. 30:1987;404-411.